Iradimed (IRMD) Operating Leases (2019 - 2024)

Iradimed (IRMD) has 6 years of Operating Leases data on file, last reported at $2000.0 in Q4 2024.

• On a quarterly basis, Operating Leases fell 99.88% year-over-year to $2000.0 in Q4 2024; TTM through Dec 2024 was $2000.0, a 99.88% decrease from a year earlier, with the FY2024 full-year figure at $2000.0, down 99.88% from the prior year.
• Operating Leases for Q4 2024 stood at $2000.0, down from $2831.0 in the prior quarter.
• Over the last five years, Operating Leases for IRMD reached as high as $2.7 million in Q1 2020 and fell as low as $2000.0 in Q4 2024.
• Historically, Operating Leases has averaged $1.8 million across 5 years, with a median of $2.0 million in 2022.
• Across the five-year window, Operating Leases fell 8.44% in 2020 and sank 99.88% in 2024, its largest moves.
• Year by year, Operating Leases stood at $2.5 million in 2020, then dropped by 10.32% to $2.2 million in 2021, then slipped by 13.32% to $1.9 million in 2022, then fell by 15.52% to $1.6 million in 2023, then sank by 99.88% to $2000.0 in 2024.
• Per Business Quant data, the three most recent Operating Leases figures were $2000.0 in Q4 2024, $2831.0 in Q3 2024, and $4231.0 in Q2 2024.